- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03321253
Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification
Changes of Macular Pigment Optical Density and Parameters After Nd: YAG Laser Posterior Capsulotomy in Cases With Posterior Capsule Opacification
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This clinical trial was conducted following the principles of the Declaration of Helsinki. The local authorized clinical trials ethics committee approved the protocol and consent forms (Afyon Kocatepe University Clinical Trials Ethics Committee, 2011-KAEK-2 2017/172). Between 2015 and 2016, 38 pseudophakic participants were enrolled in this study. After providing information to patients about the disease and treatment, patients predicted to show adherence to treatment, were enrolled in the study.
Detailed ophthalmological examinations of all subjects were performed prior to Nd: YAG laser posterior capsulotomy intervention. Anterior chamber parameters of cases with PCO were measured Measurements of IOP, anterior chamber parameters, visual acuity, Slit-lamp, gonioscopy and fundus examinations, and measurements of central macular thickness (CMT), choroidal thicknesses (CTs), and MPOD were performed after maximal pupil dilatation.
Proposed procedure, including risks, benefits, and alternatives were discussed with all subjects, and all participants signed of informed consent form.
Choroidal thicknesses were recorded as subfoveal CT (SCT), nasal CT (NCT) and temporal CT (TCT).
MPOD measurements were subsequently made by using luminance differential thresholds test. After measurements a refractive surgery specialist carried out Nd: YAG laser posterior capsulotomy interventions to patients who were decided to applying Nd:YAG laser capsulotomy.
All examinations and measurements were repeated and recorded at 1st week, 1st and 2nd month.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Best-corrected visual acuity (BCVA) logMAR <0.3
- Duration at least 2 years after cataract surgery
- Between the ages of 45 and 65 years (45≤age≤65)
Exclusion Criteria:
- Corneal scarring, diffuse posterior PCO or intravitreal hemorrhage that prevents appearance of the fundus
- Occluded angle by gonioscopy (grade 0, narrow angle, grade I, grade II)
- Presence of macular or peripheral retinal pathologies or choroidopathy
- High risk for RD
- Presence of macular edema in the macular area
- Detection of macular fluid or edema in OCT
- Active intraocular inflammation
- Previous laser PRP, Nd: YAG laser posterior capsulotomy, laser iridotomy or selective laser trabeculoplasty interventions
- Previous iridectomy, glaucoma or vitreoretinal surgery
- Glass intraocular lens
- Spherical refractive error ≥ ±6.00 D or cylinder refractive error ≥ ±3.00 D
- Inadequate stability of the eye
- Systemic diseases that may affect the choroidal blood flow such as cardiological diseases
- Current use of carotenoid supplementation
- Changing eating habits
- Gastrointestinal diseases that could cause disturbance of dietary absorption
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Interventional Model: SEQUENTIAL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Nd: YAG laser posterior capsulotomy
Posterior capsulotomy was performed by using Nd: YAG laser and macular pigment optical density, intra ocular pressure, choroidal thickness, macular thickness and anterior chamber parameters were measured before Nd: YAG laser, at 1 week, 1 month and 2 months
|
Nd: YAG laser posterior capsulotomy
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes of Foveal and Pericentral Pigment Optical Density (Log Unit) From Baseline at 2 Months
Time Frame: 2 months
|
Foveal and pericentral pigment optical density was measured by using color perimetry technique and recorded as log unit before Nd: YAG laser posterior capsulotomy, at 1 week, 1 month and 2 months
|
2 months
|
Changes of Subfoveal, Temporal and Nasal Choroidal Thicknesses (Micrometer) From Baseline at 2 Months
Time Frame: 2 months
|
Subfoveal, temporal and nasal choroidal thicknesses were measured by using enhanced-deep imaging optical coherence tomography and recorded as micrometer before Nd: YAG laser posterior capsulotomy, at 1 week, at 1-month and at 2-month
|
2 months
|
Changes of Anterior Chamber Depth (Millimeter) From Baseline at 2 Months
Time Frame: 2 months
|
Anterior chamber depth was measured by using anterior segment module optical coherence tomography and recorded as millimeter before Nd: YAG laser posterior capsulotomy, at 1 week, at 1-month and at 2-month
|
2 months
|
Changes of Iridocorneal Angle From Baseline at 2 Months
Time Frame: 2 months
|
Iridocorneal angle was measured by using anterior segment module optical coherence tomography and recorded as millimeter before Nd: YAG laser posterior capsulotomy, at 1 week, at 1-month and 2-month
|
2 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes of Central Macular Thicknesses (Micrometer) From Baseline at 2 Months
Time Frame: 2 Months
|
2 Months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011-KAEK-2 2017/172
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Retinal Degeneration
-
Seoul National University Bundang HospitalUnknownAge-Related Macular Degeneration | Retinal DrusenKorea, Republic of
-
University of LuebeckCompletedAge-Related Macular Degeneration | Retinal FunctionGermany
-
Stanford UniversityBascom Palmer Eye InstituteCompletedMacular Degeneration | Retinal DrusenUnited States
-
Guardion Health Sciences, Inc.Western University of Health Sciences; Eye Clinic of AustinCompletedMacular Degeneration | Age-related Macular Degeneration | Retinal DrusenUnited States
-
Benha UniversityRecruitingMacula Lutea DegenerationUnited Arab Emirates
-
BayerRegeneron PharmaceuticalsCompletedWet Macular DegenerationJapan
-
BayerRegeneron PharmaceuticalsCompletedWet Macular DegenerationItaly
-
BayerRegeneron PharmaceuticalsCompletedWet Macular DegenerationFrance
-
Sorlandet Hospital HFActive, not recruitingWet Macular DegenerationNorway
-
BayerRegeneron PharmaceuticalsCompletedWet Macular DegenerationFrance
Clinical Trials on Nd: YAG laser posterior capsulotomy
-
Northeastern State UniversityActive, not recruitingPosterior Capsule Opacification Obscuring VisionUnited States
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityUnknownCataract | Posterior Capsule OpacificationChina
-
Cairo UniversityCompleted
-
Aljazeera HospitalNational Research Centre, EgyptUnknown
-
Alexandria UniversityRecruitingChanges in Bacterial Count in Axilla After Laser Hair RemovalEgypt
-
Institute of Dermatology, ThailandCompletedAndrogenetic Alopecia | Hair Loss/BaldnessThailand
-
Kasr El Aini HospitalCompleted
-
Cairo UniversityCompleted
-
Cairo UniversityCompletedKeratosis PilarisEgypt